… Emergence of novel and dominant acquired EGFR solvent-… to third-generation EGFR
tyrosine kinase inhibitors. Fronti … factor receptor tyrosine kinase inhibitors (EGFR-TKIs) therapy. …

… growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) still … to EGFR-TKI has led to the
discovery of novel biomarkers … of third-generation TKIs and proposals for rational therapeutic …

… mechanisms of the third generation TKI, and the treatment strategies after drug resistance …
Investigating novel resistance mechanisms to third⁃generation EGFR tyrosine kinase inhibitor …

… growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) … of action of the third-generation
EGFR-TKI osimertinib, focused … A novel strategy of cancer diagnosis and synergistic therapy[…

… -tyrosine kinase inhibitors (EGFR-TKIs) … third-generation EGFR-TKIs resistance. In this
view, we summarize the research progress in the new generation EGFR-TKIs after third-generation…

… therapy of epidermal growth factor receptor tyrosine kinase … of acquired resistance to
third-generation EGFR-TKIs. … 剂（EGFR tyrosine kinase inhibitors, EGFR-TKIs）已成为EGFR突变…

… tyrosine kinase inhibitors (EGFR-TKIs) could improve the prognosis of patients with EGFR-…
on resistance mechanisms and overcoming strategise to thirdgeneration EGFR-TKIs in …

… therapy and immunotherapy has significantly promoted the transformation of therapeutic
strategies of … Establishing the novel pharmacogenomics of head and neck cancer based on …

… Novel D761Y and common secondary T790M mutations in … and continuation therapy beyond
progression in EGFR-mutant … to third-generation EGFR tyrosine kinase inhibitors in EGFR …

… resistance to available EGFR tyrosine kinase inhibitors (TKIs), … therapy has been approved
for NSCLC patients with EGFR … In this case, new treatment strategies using new EGFR TKIs or …